REFERENCES
- Favia G, Iacobone M. Medullary thyroid carcinoma: state of the art. G Chir 2005; 26: 405–409
- Bucsky P, Parlowsky T. Epidemiology and therapy of thyroid cancer in childhood and adolescence. Exp Clin Endocrinol Diabetes 1997; 105: 70–73
- Phay J E, Moley J F, Lairmore T C. Multiple endocrine neoplasias. Semin Surg Oncol 2000; 18: 324–332
- Edery P, Lyonnet S, Mulligan L M, et al. Mutations of the RET-protooncogene in Hirschsprung's disease. Nature 1994; 367: 378–380
- Barrows F P, Shockley W W, Wright J D, et al. Metastatic medullary thyroid cancer in a pediatric patient with MEN 2B: emphasis on the need for early recognition of extrathyroidal clinical findings associated with MEN 2B. Clin Pediatr 2006; 45: 463–467
- Leboulleux S, Travagli J P, Caillou B, et al. Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome. Cancer 2002; 94: 44–50
- Cohen MS, Phay J E, Albinson Charlotte, et al. Gastrointestinal manifestations of multiple endocrine neoplasia type 2. Ann Surg 2002; 235: 648–655
- Chong G C, Beahrs O H, Sizemore G W, et al. Medullary carcinoma of the thyroid gland. Cancer 1975; 35: 695–704
- Carney J A, Go V L, Sizemore G W, et al. Alimentary-tract ganglioneuromatosis: a major component of the multiple endocrine neoplasia, type 2B. N Engl J Med 1976; 295: 1287–1291
- Lora M S, Waguespack S G, Moley J F, et al. Adrenal ganglioneuromas in children with multiple endocrine neoplasia type 2: a report of two cases. J Clin Endocrinol Metab 2005; 90: 4383–4387
- Moley J F, DeBenedetti M K. Patterns of nodal metastasis in palpable medullary thyroid carcinoma: recommendations for extent of node resection. Ann Surg 1999; 229: 880–888
- Shields J A, Shields C L, Perez N. Choroidal metastasis from medullary thyroid carcinoma in multiple endocrine neoplasia. Am J Ophthalmol 2002; 134: 607–609
- Pacini F, Basolo F, Elisei R, et al. Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens. Am J Clin Pathol 1991; 95: 300–308
- Hoff A O, Cote G J, Gagel R F. Multiple endocrine neoplasias. Annu Rev Physiol 2000; 62: 377–411
- Cote G J, Gagel R F. Lessons learned from the management of a rare genetic cancer. N Engl J Med 2003; 128: 1566–1568
- Moore S W, Appfelstaedt J, Zaahl M G. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2. J Pediatr Surg 2007; 42: 326–332
- Barakat M T, Meeran K, Bloom S R. Neuroendocrine tumors. Endocr Relat Cancer 2004; 11: 1–18
- Moley J F. Medullary thyroid carcinoma. Curr Treat Options Oncol 2003; 4: 339–347
- Weber T, Schilling T, Frank-Raue K, et al. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Surgery 2001; 130: 1044–1049
- Shimotake T, Tsuda T, Aoi S, et al. Iodine 123 metaiodobenzylguanidine radio-guided navigation surgery for recurrent medullary thyroid carcinoma in a girl with multiple endocrine neoplasia type 2B. J Pediatr Surg 2005; 40: 1643–1646
- Strock C J, Park J I, Rosen D M, et al. Activity of irinotecan and the tyrosine kinase inhibitor CEP-751 in medullary thyroid cancer. Clin Endocrinol Metab 2006; 91: 79–84
- Chatal J F, Campion L, Kraeber-Bodere F, et al. Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group. J Clin Oncol 2006; 24: 1705–1711
- Zhen-Xian Du, Hai-Yan Zhang, Da-Xin Gao, et al. Antisurvinin oligonucleotide inhibit growth and induce apoptosis in human medullary thyroid carcinoma cells. Exp Mol Med 2006; 38: 230–240